Pharmanex® - The Measurable Difference  
pharmanews products company science opportunity contact
2005 Extraordinary Year for Pharmanex Global R&D
Science
feedback

 

 

 

nu skin enterprises
nu skin
big planet
Estera™ Phase I

Adams MR, Golden DL, Register TC et al. The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-beta. Arterioscler.Thromb.Vasc.Biol. 2002;22:1859-64.

Albertazzi P, et al. The effect of dietary soy supplementation on hot flushes. Obstet Gynecol 1998;91:6-11.

Alekel DL, St Germain A, Pererson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. American Journal of Clinical Nutrition 2000;72:844-52.

Anderson JW, Johnstone BM, Cook-Newell ML. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-282.

Anthony MS, Clarkson TB. Comparison of soy phytoestrogens and conjugated equine estrogens on atherosclerosis progression in postmenopausal monkeys (abstract). Circulation 1998;97:829.

Atkinson C, Compston JE, Day NE, Dowsett M, Bingham SA. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2004;79(2):326-33.

Aviram M, Dornfeld L, Rosenblat M et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 2000;71:1062-76.

Baber R, Clifton Bligh P, et al. The effect of an isoflavone dietary supplement (P-081) on serum lipids, forearm bone density and endometrial thickness in postmenopausal women (abstract 27). Menopause 1999;6:326.

Barnes S. Phyto-oestrogens and osteoporosis: what is a safe dose? British Journal of Nutrition 2003;89:S101-S108.

Bloedon LT, Jeffcoat AR, Lopaczynski W et al. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. American Journal of Clinical Nutrition 2002;76:1126-37.

Bohnert KJ, Hahn G. Clinical study on chaste tree for menstrual disorders. Quarterly Review of Natural Medicine 1997;Spring:19-21.

Brooks JD, Ward WE, Lewis JE et al. Supplementation with flaxseed alters estrogen metabolism in postmenopausal women to a greater extent than does supplementation with an equal amount of soy. American Journal of Clinical Nutrition 2004;79:318-25.

Brush MG, Bennett T, Hansen K. Pyridoxine in the treatment of premenstrual syndrome: a retrospective survey in 630 patients. Br J Clin Pract. 1988;42:448-52.

Brush MG, Watson SJ, Horrobin DF, Manku MS. Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. Am J Obstet Gynecol 1984;150:363-6.

Budeiri D, et al. Is Evening Primrose Oil of Value in the Treatment of Premenstrual Syndrome? Control Clin Trials. 1996;17(1):60-68

Chen J, Thompson LU. Lignans and tamoxifen, alone or in combination, reduce human breast cancer cell adhesion, invasion and migration in vitro. Breast Cancer Res Treat. 2003;80:163-70.

Cheung KL. Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in Asia. Aust N Z J Surg 1999;69:492-4.

Clarkson TB. Soy, soy phytoestrogens and cardiovascular disease. Journal of Nutrition 2002;132:566S-9S.

Constantinou AI, Mehta RG, Vaughan A. Inhibition of N-methyl-N-nitrosourea-induced mammary tumors in rats by the soybean isoflavones. Anticancer Res 1996;16(6a):3293-8

Cotter AC, Cashman KD. Genistein appears to prevent early postmenopausal bone loss as effectively as hormone replacement therapy. Nutr Rev 2004;61(10):346-51.

Crisafulli A, Marini H, Bitto A, Altavilla D, Squadrito G, Romeo A, Adamo EB, Marini R, D'Anna R, Corrado F, Bartolone S, Frisina N, Squadrito F.Effects of genistein on hot flushes in early postmenopausal women: a randomized, double-blind EPT- and placebo-controlled study. Menopause. 2004 Jul-Aug;11(4):400-4.

Cunnane SC, Hamadeh MJ, Liede AC, Thompson LU, Wolever TM, Jenkins DJ. Nutritional attributes of traditional flaxseed in healthy young adults [see comments]. Am J Clin Nutr 1995;61:62-8.

Dean PDG, Exley D, Goodwin TW. Steroid estrogens in plants: reestimation of estrone in pomegranate-D seeds. Phytochemistry 1971;10:2215-6.

Demark-Wahnefried W, Price DT, Polascik TJ et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 2001;58:47-52.

Divi RL, Chang HC, Doerge DR. Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol. Nov1997;54(10):1087-96.

Duke JA. Chasteberry. The Business of Herbs. 1995;Nov/Dec:12-13.

Evans BA, Griffiths K, Morton MS. Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol 1995;147:295-302.

Exner M, Hermann M, Hofbauer R et al. Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein. Free Radic Res 2001;34:101-12.

Fitzpatrick LA. Soy isoflavones: hope or hype? Maturitas 2003;44(suppl. 1):S21-S29.

Food and Drug Administration. Food labeling: health claims, soy protein and coronary artery disease. Federal Register 1999;64:57699-733.

Fritz WA, Coward L, Wang J, Lamartiniere CA. Dietary genistein: perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat. Carcinogenesis 1998;19:2151-8.

Gao YH, Yamaguchi M. Suppressive effect of genistein on rat bone osteoclasts: Apoptosis is induced through Ca 2+ signaling. Biol Pharm Bull 1999;22:805-809.

Gao YH, Yamaguchi M. Zinc enhancement of genistein's anabolic effect on bone components in elderly female rats. Gen.Pharmacol 1998;31:199-202.

Guo TL, McCay JA, Zhang LX et al. Genistein modulates immune responses and increases host resistance to B16F10 tumor in adult female B6C3F1 mice. Journal of Nutrition 2001;131:3251-8

Haggans CJ, Hutchins AM, Olson BA, Thomas W, Martini MC, Slavin JL. Effect of flaxseed consumption on urinary estrogen metabolites in postmenopausal women. Nutr Cancer 1999;33:188-95.

Haggans CJ, Travelli EJ, Thomas W, Martini MC, Slavin JL. The effect of flaxseed and wheat bran consumption on urinary estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2000;9:719-25.

Henderson VW. Isoflavones: food for thoughtful consideration. Menopause. 2003;10:189-90.

Higdon, J. (2003).An Evidence-Based Approach to Vitamins and Minerals Health Benefits and Intake Recommendations. Linus Pauling Institute: Thieme

Hobbs, C. and M. Blumenthal. 1999. Vitex agnus-castus: A Literature Review. HerbalGram 47 (in Press) Retrieved from www.herbalgram.org

Horrobin DF. The Role of Essential Fatty Acids and Prostaglandins in the Premenstrual Syndrome. J Reprod Med. 1983;28:465-68.

Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 1998;58:3833-8.

Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL. Flaxseed influences urinary lignan excretion in a dose-dependent manner in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2000;9:1113-8.

Hutchins AM, Martini MC, Olson BA, Thomas W, Slavin JL. Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women. Nutr Cancer 2001;39:58-65.

Jarry H, Leonhardt S, Wuttke W, et al. Agnus castus as a dopaminergic active prinicple in Mastodyn® N. Zeitschrift fur Phytotherapie 1991;12:77-82.

Jenab M, Rickard SE, Orcheson LJ, Thompson LU. Flaxseed and lignans increase cecal beta-glucuronidase activity in rats. Nutr Cancer 1999;33:154-8.

Jenab M, Thompson LU. The influence of flaxseed and lignans on colon carcinogenesis and beta-glucuronidase activity. Carcinogenesis 1996;17:1343-8.

Jiminez del Rio M. Pomegranate extract: the fruit of healthy cholesterol and longevity. Nutraceuticals World 2001.

Kendall KE, Schnurr PP. The effects of vitamin B6 supplementation on premenstrual symptoms. Obstet Gynecol 1987;70:145-9.

Kenny FS, Pinder SE, Ellis IO et al. Gamma linolenic acid with tamoxifen as primary therapy in breast cancer. Int J Cancer 2000;85:643-8.

Khoo SK, et al. Evening Primrose Oil and Treatment of Premenstrual Syndrome. Med J Aust. 1990;153(4):189-92.

Kim ND, Mehta R, Yu W et al. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat. 2002;71:203-17.

Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr 1998;128:954-9.

Kitts DD, Yuan YV, Wijewickreme AN, Thompson LU. Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone. Mol.Cell Biochem 1999;202:91-100.

Knight DC, Howes JB, Eden JA. The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999;2:79-84.

Kritz-Silverstein D, Von Muhlen D, Barrett-Connor E, Bressel MA. Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause. 2003;10:196-202.

Li B, Yu S. Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation. Biol Pharm Bull 2003;26:780-6.

Li D, Yee JA, Thompson LU, Yan L. Dietary supplementation with secoisolariciresinol diglycoside (SDG) reduces experimental metastasis of melanoma cells in mice. Cancer Lett 1999;142:91-6.

Loch EG, Selle H, Boblitz N. Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Womens Health Gend.Based.Med 2000;9:315-20.

Mathern J, Verbruggen M. Special report: Flax lignans. Total Health 2003;1-15

Messina M, Flickinger B. Hypothesied anticancer effects of soy: Evidence points to isoflavones as the primary anticarcinogens. Pharmaceutical Biology 2002:40(supplement):6-23.

Messina M, Hughes C. Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency. J Medicinal Food 2003;6(1):1-11.

Milewicz A, Gejdel E, Sworen H et al. Vitex agnus castus-Extrakt behandlung von Regeltempoanomalien infolge latenter Hyperprolaktinamie [Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo- controlled double-blind study]. Arzneimittelforschung. 1993;43:752-6.

Miller CP, Collini MD, Harris HA. Constrained phytoestrogens and analogues as ER-beta selective ligands. Bioorg Med Chem Lett 2003:13(14):2399-403.

Morabito N, Crisafully A, et al. Effects of Genistein and Hormone-Replacement Therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J Bone Min Res 2002;17;1904-1912.

Murkies AL, Lombard C, Strauss BJG, Wilcox G, Burger HG, Morton MS. Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas 1995;21:189-95.

Nagata C, Takatsuka N, Kawakami N, Shimizu H. A prospective cohort study of soy product intake and stomach cancer death. Br.J.Cancer 2002;87:31-6.

North American Menopause Society. Menopause 2000;7(4):215-229.

North American Menopause Society. The role of isoflavones in menopausal health: Consensus opinion of the

Okazaki K, Okazaki S, Nakamura H et al. A repeated 28-day oral dose toxicity study of genistein in rats, based on the 'Enhanced OECD Test Guideline 407' for screening endocrine-disrupting chemicals. Archives of Toxicology 2002;76:553-9.

Phipps WR, Martini MC, Lampe JW, Slavin JL, Kurzer MS. Effect of flax seed ingestion on the menstrual cycle. J Clin Endocrinol.Metab 1993;77:1215-9.

Plumb GW, Pascual-Teresa S, Santos-Buelga C, Rivas-Gonzalo JC, Williamson G. Antioxidant properties of gallocatechin and prodelphinidins from pomegranate peel. Redox.Rep. 2002;7:41-6.

Potter SM, Baum JA, et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998;68(suppl):1375S-9S.

Prasad K, Mantha SV, Muir AD, Westcott ND. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 1998;136:367-75.

Prasad K. Antioxidant Activity of Secoisolariciresinol Diglucoside-derived Metabolites, Secoisolariciresinol, Enterodiol, and Enterolactone. International Journal of Angiology 2000;9:220-5.

Prasad K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis. Atherosclerosis 1997;132:69-76.

Prasad K. Hydroxyl radical-scavenging property of SDG isolated from flaxseed. Mol Cell Biochem 1997;168:117-123.

Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation 1999;99:1355-62.

Prasad K. Secoisolariciresinol diglucoside from flaxseed delays the development of type 2 diabetes in Zucker rat. J Lab Clin Med 2001;138:32-9.

Rickard DJ, Monroe DG, Ruesink TJ, Khosla S, Riggs BL, Spelsberg TC. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta. J Cell Biochem 2003;89:633-46.

Rickard SE, Yuan YV, Chen J, Thompson LU. Dose effects of flaxseed and its lignan on N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats. Nutr Cancer 1999;35:50-7.

Rickard SE, Yuan YV, Thompson LU. Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside. Cancer Lett 2000;161:47-55.

Ritchie CD, Singkamani R. Plasma pyridoxal 5'-phosphate in women with the premenstrual syndrome. Hum Nutr Clin Nutr 1986;40:75-80.

Rivas M, Garay RP, Escanero JF, Cia P, Jr., Cia P, Alda JO. Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J Nutr 2002;132:1900-2.

Scheiber MD, Setchell KDR, et al. Dietary soy supplementation influences LDL oxidation and bone turnover in healthy postmenopausal women. Presented at the 81st Meeting of the Endocrine Society, San Diego, CA, June 1999.

Schellenberg R. Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study. Bmj 2001;%20;322:134-7.

Serraino M, Thompson LU. Flaxseed supplementation and early markers of colon carcinogenesis. Cancer Lett 1992;63:159-65.

Setchell KD, Faughnan MS, Avades T et al. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 2003;77:411-9.

Singh RP, Chidambara Murthy KN, Jayaprakasha GK. Studies on the antioxidant activity of pomegranate (Punica granatum) peel and seed extracts using in vitro models. J Agric Food Chem 2002;50:81-6.

Snow JM. Vitex agnus-castus L. (Verbenaceae). Protocol Journal of Botanical Medicine 1996;Spring:20-23.

Somekawa Y, Chiguchi M, Ishibashi T, Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women. Obstet Gynecol 2001;97:109-15.

Tan KP, Chen J, Ward WE, Thompson LU. Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats. Exp Biol Med (Maywood.) 2004;229:147-57.

Thompson LU, Rickard SE, Orcheson LJ, Seidl MM. Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. Carcinogenesis 1996;17:1373-6.

Tikkanen MJ, Wahala K, Ojala S, Vihma V, Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci USA 1998;95:3106-10.

Toi M, Bando H, Ramachandran C et al. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis. 2003;6:121-8.

ung MK, Lautens M, Thompson LU. Mammalian lignans inhibit the growth of estrogen-independent human colon tumor cells. Anticancer Res 1998;18:1405-1408.

Upmalis D, Lobo R, Bradley L. Evaluation of the safety and efficacy of an oral soy extract in the treatment of vasomotor symptoms in menopausal women (abstract 30). Menopause 1999;6:327.

USDA-Iowa State University Database on the Isoflavone Content of Foods, Release 1.3 – 2002 www.nal.usda.gov/fnic/foodcomp/Data/isoflav/isoflav.html

van Elswijk DA, Schobel UP, Lansky EP, Irth H, van der GJ. Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry. Phytochemistry 2004;65:233-41.

Wagner JD, Schwenke DC, Greaves KA et al. Soy protein with isoflavones, but not an isoflavone-rich supplement, improves arterial low-density lipoprotein metabolism and atherogenesis. Arterioscler.Thromb.Vasc.Biol. 2003;23:2241-6.

Washburn S, Burke GL, Morgan T, Anthony MS. Effect of soy protein supplementation on serum lipoproteins, blood pressure and menopausal symptoms in perimenopausal women. Menopause 1999;6:7-13.

Wu J, Wang XX, Chiba H et al. Combined intervention of exercise and genistein prevented androgen deficiency-induced bone loss in mice. J Appl Physiol 2003;94:335-42.

Yan L, Yee JA, Li D, McGuire MH, Thompson LU. Dietary flaxseed supplementation and experimental metastasis of melanoma cells in mice. Cancer Lett 1998;124:181-6.

Yuan YV, et al. Short-term feeding of flaxseed or its lignan has minor influence on in vivo hepatic antioxidant status in young rats. Nutr Res 1999;19:1233-1243.

Zhang Y, et al. Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J Nutr 1999 Feb;129(2):399-405.

Home  :  Nu Skin Enterprises  :  Live Better Longer  :  Force for Good  :  Nourish the Children  :  Site Map